Citius Oncology, Inc. (CTOR) — Financial Flexibility Index
Citius Oncology, Inc. (CTOR) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $5.00) represents 0% of total liabilities ($65.43 Million). Check CTOR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Citius Oncology, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Citius Oncology, Inc. across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Citius Oncology, Inc..
Annual Financial Flexibility Index for Citius Oncology, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Citius Oncology, Inc.. Explore Citius Oncology, Inc. (CTOR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.10x | $-5.49 Million | $-5.49 Million | $56.08 Million | ▼ -3063.1% |
| 2024 | 0.00x | $126.36K | $126.35K | $38.23 Million | ▲ +112.2% |
| 2023 | -0.03x | $-601.30K | $-601.30K | $22.20 Million | ▼ -262.7% |
| 2022 | -0.01x | $-47.97K | $-47.97K | $6.42 Million | — |